产品描述: Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells. |
靶点:
Apoptosis;TNF;Apoptosis; TNF |
细胞实验:
Dose-response curves of bioymifi and A2C2 in T98 g cells are plotted as a function of A2C2 or bioymifi concentration. Human glioblastoma (T98 g) cells are treated with various concentrations of A2C2 or bioymifi alone or in combination with 1 μM Smac mimetic (SM) for 48 h. The corresponding cell survival is normalized to the treatment without A2C2 or bioymifi.(Only for Reference) |
参考文献:
1.Wang G, et al. Nat Chem Biol. 2013, 9(2):84-9. |
溶解性:
DMSO:87 mM |
保存条件:
-20℃ |
配置溶液浓度参考:
|
1mg |
5mg |
10mg |
1 mM |
0 ml |
0 ml |
0 ml |
5 mM |
0 ml |
0 ml |
0 ml |
10 mM |
0 ml |
0 ml |
0 ml |
50 mM |
0 ml |
0 ml |
0 ml |
|
注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |